"ALOFT - Aliskiren Observation of Heart Failure Treatment": Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure

Inclusion Criteria: * History of diagnosis or currently have high blood pressure * Stable heart failure (NYHA Class 2-4) for at least 1 month before study entry. Subject should be on a stable dose regimen of heart failure medication. * Brain natriuretic peptide (BNP) \> 150 pg/ml at baseline (to be evaluated by physician at first visit) Exclusion Criteria: * Previous treatment with aliskiren * High blood pressure due to secondary reasons or constant low blood pressure (systolic \< 90 mmHg) * History of heart attack or coronary bypass surgery in the past 6 months Other protocol-defined exclusion criteria may apply.